A detailed history of Apg Asset Management N.V. transactions in Abb Vie Inc. stock. As of the latest transaction made, Apg Asset Management N.V. holds 336,773 shares of ABBV stock, worth $56.5 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
336,773
Previous 1,751,073 80.77%
Holding current value
$56.5 Million
Previous $300 Million 77.86%
% of portfolio
0.42%
Previous 0.51%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $232 Million - $282 Million
-1,414,300 Reduced 80.77%
336,773 $66.5 Million
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $2.47 Million - $2.89 Million
15,962 Added 0.92%
1,751,073 $300 Million
Q1 2024

May 14, 2024

SELL
$159.82 - $182.1 $15 Million - $17.1 Million
-93,632 Reduced 5.12%
1,735,111 $316 Million
Q4 2023

Feb 13, 2024

SELL
$137.6 - $154.97 $1.9 Million - $2.14 Million
-13,791 Reduced 0.75%
1,828,743 $283 Million
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $22.2 Million - $25.7 Million
-166,097 Reduced 8.27%
1,842,534 $275 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $6.95 Million - $8.65 Million
-52,451 Reduced 2.54%
2,008,631 $271 Million
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $48.2 Million - $55.5 Million
-333,553 Reduced 13.93%
2,061,082 $328 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $266 Million - $319 Million
1,921,157 Added 405.75%
2,394,635 $387 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $17.3 Million - $19.8 Million
128,602 Added 37.29%
473,478 $64.9 Million
Q2 2022

Aug 12, 2022

BUY
$137.62 - $174.96 $9.45 Million - $12 Million
68,661 Added 24.86%
344,876 $50.5 Million
Q1 2022

May 12, 2022

SELL
$131.98 - $163.75 $9.83 Million - $12.2 Million
-74,505 Reduced 21.24%
276,215 $40.2 Million
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $4.63 Million - $5.86 Million
43,098 Added 14.01%
350,720 $41.8 Million
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $6.84 Million - $7.77 Million
-64,300 Reduced 17.29%
307,622 $28.6 Million
Q2 2021

Aug 13, 2021

SELL
$105.21 - $117.21 $18.9 Million - $21.1 Million
-179,717 Reduced 32.58%
371,922 $35.3 Million
Q1 2021

May 14, 2021

SELL
$102.3 - $112.62 $45.1 Million - $49.7 Million
-440,921 Reduced 44.42%
551,639 $50.8 Million
Q4 2020

Feb 12, 2021

SELL
$80.49 - $108.67 $56.3 Million - $76 Million
-699,791 Reduced 41.35%
992,560 $86.9 Million
Q3 2020

Nov 12, 2020

SELL
$85.91 - $100.83 $25.9 Million - $30.3 Million
-300,969 Reduced 15.1%
1,692,351 $126 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $18.3 Million - $24.6 Million
250,096 Added 14.35%
1,993,320 $174 Million
Q1 2020

May 15, 2020

BUY
$64.5 - $97.79 $79 Million - $120 Million
1,225,041 Added 236.41%
1,743,224 $133 Million
Q1 2020

May 14, 2020

SELL
$64.5 - $97.79 $12.9 Million - $19.6 Million
-199,929 Reduced 27.84%
518,183 $37.2 Million
Q4 2019

Feb 13, 2020

BUY
$72.13 - $90.25 $3.79 Million - $4.75 Million
52,600 Added 7.9%
718,112 $56.6 Million
Q3 2019

Nov 08, 2019

BUY
$62.98 - $75.72 $354,514 - $426,227
5,629 Added 0.85%
665,512 $46.2 Million
Q2 2019

Aug 13, 2019

BUY
$65.7 - $83.98 $9.31 Million - $11.9 Million
141,700 Added 27.35%
659,883 $42.1 Million
Q1 2019

May 14, 2019

SELL
$77.14 - $90.79 $204 Million - $240 Million
-2,638,100 Reduced 83.58%
518,183 $37.2 Million
Q4 2018

Feb 13, 2019

BUY
$77.85 - $96.01 $39.4 Million - $48.6 Million
506,700 Added 19.12%
3,156,283 $255 Million
Q3 2018

Nov 09, 2018

BUY
$88.91 - $98.84 $25.8 Million - $28.7 Million
290,500 Added 12.31%
2,649,583 $216 Million
Q2 2018

Aug 13, 2018

SELL
$89.78 - $106.23 $1.39 Million - $1.65 Million
-15,500 Reduced 0.65%
2,359,083 $187 Million
Q1 2018

May 14, 2018

BUY
$92.01 - $123.21 $6.84 Million - $9.15 Million
74,300 Added 3.23%
2,374,583 $183 Million
Q4 2017

Jan 24, 2018

BUY
$89.56 - $98.21 $29.4 Million - $32.2 Million
327,974 Added 16.63%
2,300,283 $185 Million
Q3 2017

Oct 19, 2017

BUY
$69.85 - $89.22 $138 Million - $176 Million
1,972,309
1,972,309 $175 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $297B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Apg Asset Management N.V. Portfolio

Follow Apg Asset Management N.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

News

Stay updated on Apg Asset Management N.V. with notifications on news.